with pregnancies in the general population. 4 Balayla and colleagues note that "low elasticity and increased stiff ness" in arteries of the post-menopausal uterus (age 63 at childbirth) might be the underlying cause of pre-eclampsia. Whether decreased elasticity (measured in the carotid, aorta, or radial artery) predisposes patients to pre-eclampsia or whether stiff ness is a result of pre-eclampsia is unclear. 5 To our knowledge, no studies of elasticity of uterine arteries exist. Our clinical observation from hundreds of open radical hysterectomies, with inclusion of the entire uterine artery, is that arterial stiff ness is very rarely present in uterine arteries, although the lower aorta and the external iliac can be aff ected. Balayla and colleagues 6 suggested that uterine arteries could be used for coronary bypass surgery, because of their high density of oestrogen α receptors, with associated antiatherosclerotic properties. Nevertheless, if dysfunction of uterine vessels or the placental bed pre-existed, we would have seen this with Doppler studies, which was not the case. 1 Balayla and colleagues raise concerns about informed consent of the recipient and donor, and mention that aspirin might not have been used to prevent pre-eclampsia. We clearly state in our Article 1 that informed consent was given by all participants. The psychosocial circumstances of this consent will be discussed in future publications. All recipients received daily doses of 75 mg (low dose) aspirin from the day of uterus transplantation and until graft removal. This treatment is unfortunately not mentioned in our report of the livebirth, 1 but is clearly stated in our initial report 7 of the uterus transplantation trial.
The fact that pre-eclampsia did not develop in the two transplant recipients (both with two kidneys) of the subsequent two livebirths in our cohort (unpublished) suggests that presence of only one kidney might
Authors' reply
We thank Pentti Heinonen and Jacques Balayla and colleagues for their valuable opinions about development of pre-eclampsia in the patient who delivered the fi rst baby from a transpl anted uterus. 1 In our Article, 1 we mention that presence of a single kidney and aged uterus, in combination with other factors, might be underlying causes for preeclampsia in this patient.
Heinonen suggests that unilateral renal agenesis of this patient, with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, was the probable reason for pre-eclampsia. MRKH syndrome is associated with malformations of the renal system in more than 20% of patients, and unilateral renal agenesis is the most frequent defect. 2 In a study 3 of more than 200 Finnish women with uterine abnormalities, Heinonen reported a 2·3 times increased risk of gestational hypertension and preeclampsia in patients with unilateral renal agenesis, compared with those with similar uterine malformations and two kidneys. Further support for association between presence of only one kidney and pre-eclampsia is that women with one kidney after kidney donation 4, 5 have increased risk of pre-eclampsia compared with pre-donation pregnancies of the same patients and compared patient, and is likely to be a contributing factor in development of pre-eclampsia. Mats Brännström and colleagues 1 reported the first livebirth after uterus transplantation. The pregnancy was complicated by preeclampsia, resulting in preterm delivery. Immunosuppression, aged uterus, and assisted reproductioni n d i v i d u a l l y o r t o g e t h e rmight explain development of pre-eclampsia. The patient had congenital absence of uterus and vagina associated with unilateral renal agenesis. Presence of only one kidney is thought to be a possible risk factor for pre-eclampsia in kidney donors. Gestational hypertension or pre-eclampsia are more likely to be diagnosed in kidney donors than in healthy non-donors. 2 A close embryologic relation exists between development of urinary and reproductive organs. Urologic abnormalities are seen in 20-30% of women with uterine anomalies, unilateral renal agenesis being the most common defect. Women with one kidney and a malformed uterus have more than twice the risk of development of gestational hypertension, proteinuria, and lateonset pre-eclampsia compared with those with a similar uterine anomaly but two normal kidneys. 3 When presence of one kidney is congenital, the kidney is usually substantially enlarged, constituting compensatory hypertrophy, without renal dysfunction. This enlargement is likely to have occurred in Brännström and colleagues'
